Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0 on the Record History page, indicating a new version of the study record.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision history updated: a new entry v3.4.3 was added and the entry for v3.4.2 was removed.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedRecord history shows a new revision v3.4.2 added and an older revision v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision history shows a new entry, v3.4.1, and removal of v3.4.0, indicating a minor update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedUI updates include a glossary display, color-coded change highlights, and the revision label v3.4.0, while 'No FEAR Act data' and the previous revision label v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check72 days agoChange DetectedA new revision version (v3.3.4) was added to the history and the previous revision (v3.3.3) was removed.SummaryDifference0.1%

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.